ACE Report Cover
Pharmacokinetic, safety, and efficacy evaluation of Ibogaine in drug detoxification
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2022;10(11):35 Ann N Y Acad Sci. 2000 11-Apr;():. 10.1111/j.1749-6632.2000.tb05213.x
Study Summary

Twenty-seven treatment-seeking opioid and cocaine dependent participants were assigned to one of three (500mg, 600mg, 800mg) doses of ibogaine in an open-label case series study. Opioid and cocaine craving, Beck Depression Inventory (BDI), and serum concentrations of ibogaine and noribogaine were examined. Ibogaine significantly decreased craving for cocaine and heroin during detoxification, and also showed lower BDI scores 30 days after detoxification. Biochemical analysis showed that ibogaine is cleared rapidly from the blood, but levels of noribogaine can remain elevated much longer.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
Are you affiliated with one of our partner associations?

Click here to gain complimentary access as part your association member benefits!

0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Your account will be affiliated with
and includes free access to OrthoEvidence


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

How to cite this ACE Report

OrthoEvidence. Pharmacokinetic, safety, and efficacy evaluation of Ibogaine in drug detoxification. OE Journal. 2022;10(11):35. Available from: https://myorthoevidence.com/AceReport/Show/pharmacokinetic-safety-and-efficacy-evaluation-of-ibogaine-in-drug-detoxification

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report